NCT07078760

Brief Summary

The LINEAR study is designed to compare the procedural efficacy, efficiency and safety of linear radiofrequency ablation of the cavotricuspid istmus using either a standar irrigated-tip ablation catheter or lattice-tip ablation catheter .The primary focus of the acute procedural data analysis will be: Procedural efficacy: This will be evaluated based on the rate of bidirectional CTI block persistence after 60 min waiting period documented by high resolution activation mapping. Furthermore, provocative test with intravenous adenosine infusion will be conducted to exclude dormant CTI conduction. Procedural efficiency: This will be evaluated based on the number of RF lesions delivered, time to achieve bidirectional CTI block, and fluoroscopy exposure time. Procedural safety: The incidence of procedural complications will be recorded.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 16, 2025

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

July 4, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

July 22, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 11, 2025

Completed
6 months until next milestone

Results Posted

Study results publicly available

June 17, 2026

Completed
Last Updated

June 17, 2026

Status Verified

May 1, 2026

Enrollment Period

6 months

First QC Date

July 4, 2025

Results QC Date

April 27, 2026

Last Update Submit

May 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Achievement of Bidirectional CTI Block After 60 Min Waiting Period Documented by High Resolution Activation Mapping

    The primary procedural endpoint for efficacy will be the achievement of bidirectional CTI block after a 60 minute waiting period assessed by high resolution activation mapping and adenosine testing.

    60 minutes

Secondary Outcomes (5)

  • Number of Participants With First-pass CTI Block

    Intraproceduraly

  • Total Ablation Time

    Intraproceduraly

  • Number of Ablation Lesions

    Intraproceduraly

  • Total Fluoroscopy Time

    From randomization to the end of the index procedure

  • Total Fluoroscopy Dose

    From randomization to the end of the index procedure

Study Arms (2)

CTI radiofrequency ablation with lattice-tip catheter

ACTIVE COMPARATOR

Patients undergoing CTI catheter ablation using RF energy delivered by the lattice-tip, dual-energy catheter (Sphere-9, Medtronic).

Procedure: CTI radiofrequency ablation.

CTI radiofrequency ablation performed with irrigated-tip catheter

ACTIVE COMPARATOR

Patients undergoing CTI catheter ablation using RF energy delivered by the irrigated RF catheter (ThermoCool® SmartTouch™, Biosense Webster, USA).

Procedure: CTI radiofrequency ablation.

Interventions

Cavotricuspid Isthmus ablation

CTI radiofrequency ablation performed with irrigated-tip catheterCTI radiofrequency ablation with lattice-tip catheter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients above 18 years of age undergoing CTI ablation

You may not qualify if:

  • Prior right atrium ablation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mitera General Hospital

Athens, Attikis, 11523, Greece

Location

Related Publications (1)

  • Tzeis S, Asvestas D, Sousonis V, Vavouris E, Karakasis P, Charitos D, Karanikas S, Pamporis K, Vardas P, Vlachos K. Lattice-tip vs. standard irrigated focal-tip catheter for radiofrequency ablation of the cavotricuspid isthmus - the LINEAR randomized trial. Europace. 2026 Mar 30;28(4):euag046. doi: 10.1093/europace/euag046.

Results Point of Contact

Title
Stylianos Tzeis
Organization
Mitera Hospital

Study Officials

  • Stylianos Tzeis, MD, PhD, FEHRA

    Mitera Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, FEHRA, Cardiologist - Electrophysiologist

Study Record Dates

First Submitted

July 4, 2025

First Posted

July 22, 2025

Study Start

June 16, 2025

Primary Completion

December 11, 2025

Study Completion

December 11, 2025

Last Updated

June 17, 2026

Results First Posted

June 17, 2026

Record last verified: 2026-05

Locations